The current state of the US economy depends on where you look and whom you ask. Starting with the positive, the Federal Reserve’s policies appear to have stuck the “soft landing”, with February inflation numbers coming in lower than expected, while the unemployment rate has remained relatively stable. However, markets were not given a chance to celebrate this, as President Trump’s escalating trade war has sent stocks tumbling and produced the first market “correction” since 2023. Despite these tariffs impacting a variety of crucial medical products, investor confidence in the largest public healthcare companies has ticked up, in contrast to the American tech sector. Healthcare may not be recession-proof, but as long as people remain employed and can cover the necessities, they will continue to seek healthcare services. However, if the most pessimistic predictions, such as the Atlanta Fed’s 2.4 percent GDP contraction for Q1 2025, come true, the broader economic fallout will surely find its way into healthcare, as consumers will spend less on healthcare, capital will be harder to come by, and public funding will diminish.